Ignite Creation Date:
2025-12-24 @ 12:04 PM
Ignite Modification Date:
2026-02-03 @ 7:54 AM
Study NCT ID:
NCT03832361
Status:
RECRUITING
Last Update Posted:
2025-07-18
First Post:
2019-02-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
Sponsor:
Organization: